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ABSTRACT  
Mucuna pruriens, also known as Velvet Bean, Mucuna pruriens has been used for centuries by Ayurvedic herbalists for overall wellness. Mucuna 
pruriens provides support for brain function, muscle health and libido. Mucuna pruriens has also been shown to have diuretic effects. It 
increases tissue resiliency and improves coordination. Mucuna can also increase testosterone levels, which in turn can lead to increased muscle 
mass and strength. It also supports the nervous and reproductive systems in the body. anti-oxidant activity of M. pruriens has been also 
demonstrated in vitro by its ability to scavenge DPPH radicals and reactive oxygen species. This is an excellent natural source of L-dopa and 5-
hydroxy tryptophan (5-HT) Present study was designed to evaluate the anti-anxiety activity of Mucuna pruriens extract in Swiss albino mice. 
Three doses of Mucuna pruriens (100, 200,400 mg/kg, p.o.) and standard dose of Buspirone (5 mg/kg, i.p.) were used for evaluation of the anti-
anxiety activity. The elevated plus maze (EPM) was used to take as a measure of antianxiety effect. Mucuna pruriens at the doses of 200 mg/kg 
and 400 mg/kg significantly reduced the time spent and no. of entries in closed arm, increased the time spent and entries into open arm in 
elevated plus maze (p<0.05) as compared to control group. These results indicate that MP may be possesses antianxiety property. 
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Anxiety is fretted about upcoming events and fear is a 
reaction to ongoing circumstances. These feelings may cause 
physical symptoms such as a racing heart and shakiness 
nervousness, panic, restlessness, tension, and agitation 1. 
Anxiety disorders are partly hereditary but it may also be 
due to some drug use including caffeine and alcohol. They 
often occur with other mental disorders. It may be treated 
with lifestyle changes, therapy, and medications. 
Medications should be recommended only if other measures 
are not effective 2.  The Neurotransmitters which involved in 
anxiety generation include noradrenaline, dopamine, GABA, 
serotonin, Corticotropin   releasing factor (CRF), 
neurosteroids neuropeptides and Melanocyte stimulating 
hormone (MSH) 3.  
Buspirone is an anxiolytic psychoactive drug of the 
azapirone chemical class. It is primarily used to treat 
generalized anxiety disorder (GAD). Unlike most drugs 
typically used to treat anxiety, but the pharmacology of 
buspirone is not associated to benzodiazepines or 
barbiturates, therefore   the risk of withdrawal symptoms 
abolished after discontinued 4.  Buspirone works as a 
serotonin 5-HT1A receptor partial agonist. This action is 
belief to arbitrate its anx-iolytic and antidepressant effects. 
Besides, it works as a presynaptic dopamine antagonist at 
the D2, D3 and D4 5 receptors. Buspirone is also a partial α1 
receptor agonist. The ability of buspirone to selectively block 
presynaptic mesolimbic D2 autoreceptors in lower doses 
appears to result in increased dopamine synthesis and 
release 6. The    anxiolytic   effects   of non-benzo- diazepine 
azapirones agents i.e. buspirone, act as 5HT1A partial   
agonists and   their   therapeutic role in clinical anxiety and 
mood disorders has further focused attention on the 5-HT1A 
receptor.  
Although the azapirones interact with dopaminergic and 
noradrenergic neurotransmitter systems, they   show   
nanomolar empathy   for 5HT1A receptor sites.7 Mucuna 
pruriens (L.) DC. Belongs to family Fabaceae. Popularly 
known as “Konch” in Hindi, “Velvet bean” in English   
Mucuna pruriens (L.) has been used for centuries in the 
Indian traditional medicine 8. The main constituents found in 
Mucuna pruriens include, dopamine, fatty acids, flavones, 
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glutamic acid, alkaloids, glutathione, histidine, gallic acid, 
hydroxygenistein, mucunadine, glycine, mucunain, 
mucunine, trypsin, tryptamine, histamine, 5-
hydroxytryptamine and it possesses various other 
pharmacological activities 9, Mucunapruriensalso showed 
significant antidepressant activity in rodent models 10. 
Previous studies have reported that Mucuna pruriens 
contains L-DOPA and 5-hydroxy tryptophan (5-HTP) as a 
major constituent with higher concentration in seeds 11. 
MATERIAL AND METHOD 
Animals The study was conducted in the   Pharmacology LAB 
Institute of Pharmacy Bundelkhand University, Jhansi.  
permission was sought   from the Institutional Animal Ethics 
Committee (IAEC) for conducting the study [Project no. 
BU/Pharm/IAEC/13/24]. Adult healthy male Swiss Albino 
mice, of similar physical constitution (in terms of age, body 
weight), weighing 20-30 g had been used in study. Animals 
had been obtained from animal house of DRDE, Gwalior, 
which is certified by Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA) for 
breeding and housing of animals. The animals were housed 
in our Institutional Animal facility under temperature, 
humidity and light and dark cycle-controlled environment 
[25 ± 2°C, 70%, 12 hrs. cycle) and were given standard pellet 
diet and water ad libitum. All the animals were treated and 
housed as per the norms of CPCSEA and IAEC. 
Drugs  
Mucuna pruriens (MP) seed extract was procured from 
Baidyanath Ayurveda Bhawan, Jhansi, India, Buspirone as 
tablets, with each tablet containing 15 mg of Buspirone 
hydrochloride were manufactured by Zydus Cadila 
Healthcare Ltd. (Alidac) Tablets were crushed and then 
dissolved in   distilled water.  
Dosage and Treatment  
Buspirone was administered in a dose of 5 mg/kg, i.p. 12.  MP 
dissolved in distilled water and administered per-orally 
(p.o.). 30 mice were divided into control and experimental 
groups (n=6). Group First received the Distilled water and 
functioned as the control group, group second received the 
standard drug Buspirone (5 mg/kg) i.p, groups third, fourth 
and fifth received the test drug (MP) in doses of 100, 200 
and 400 mg/kg, per-orally. 
Elevated Plus Maze 
The plus maze apparatus was designed as describe in hand 
book of experimental pharmacology by S.K. Kulkarni. The 
plus maze apparatus consists of two open (16 × 5 cm) and 
two closed arms (16 × 5 × 12 cm) for mice and an open roof 
with the entire maze elevated (25 cm) from the floor the 
animals are placed individually at the end of one arm facing 
away from the central platform.  
The time taken by the animals to move from the open arm to 
either of two sides of enclosed arms was recorded. The 
mouse was taken away from the apparatus when it came out 
of the enclosed arm 13. 
Statistical Analysis 
The data were expressed as mean ± standard error mean 
(SEM). The significance of differences among the groups was 
assessed using one-way analysis of variance (ANOVA). The 
test was followed by Dunnett’s test, p< 0.05 were considered 
as significance. 
RESULT 
Observed the distilled water treated group animals in EPM, 
the time spent in the open arms and closed arms, and entries 
in the open arms and closed arms were compared with 
Mucuna pruriens extract at the dose of 100 mg/kg, 200 
mg/kg and 400 mg/kg & standard drug Buspirone (5 
mg/kg). MPE at the dose of 200 mg/kg and 400 mg/kg 
showed significant (p<0.05) increase in the time spent in the 
open arms and at the dose of 400 mg/kg it showed 
significant (p<0.05) increase in number of entries in open 
arm (Graph 2).  
Furthermore, MPE 200 and 400 mg/kg had decrease in time 
spent and number of entries in closed arm (Table 1) as 
compared to control group showed a significant (p<0.05) in 
elevated plus-maze. In this experimental model MP extract 
showed significant results in dose dependent increase in 
time spent in open arm as well as number of entries in open 
arm, also the maximum time spent in open arm is with 
maximum dose i.e.400 mg/kg. (table 2) come next the dose 
0f 200 mg/kg and least time spent with dose 100 mg/kg.as 
compared to control group, so, it is significant at the dose of 




Table 1: Effect of Mucuna pruriens in Mice using EPM on EPM in mice 
GROUP 
Time spent in seconds (Mean±SD) No. of entries (Mean±SD) 
Open arm Close arm Open arm Close arm 
Distilled water 12.25±1.14 192.24±11.25 2.30±1.25 10.45±2.45 
Buspirone (5 mg/kg) 98.22±2.06** 128.35±5.20** 12.03±1.48** 09.47±1.28** 
Mucuna pruriens (100 mg/kg) 32.200±2.38 154.20±7.34 3.40±.84 09.40±1.35 
Mucuna pruriens (200 mg/kg) 42.11±2.39** 175.13±6.78* 4.11±2.11 12.27±2.10* 
Mucuna pruriens (400 mg/kg) 82.28±6.28** 125.39±3.96** 11.40±1.45** 7.23±1.22** 
p-value < .01## < .01## < .01## < .01## 
Values expressed as mean ± SEM., n=6, One-way ANOVA followed by Dunnett’s test. * p< 0.05, ** p< 0.01 considered significant 
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Figure 1A: Effect of Mucuna pruriens (MP) and Buspirone (5 mg/kg) in open arm in Elevated Plus Maze Apparatus 
 
 
Figure 1B: Effect of Mucuna pruriens (MP) and Buspirone (5 mg/kg) in closed arm in Elevated Plus Maze Apparatus 
The column represents the mean of the time spent in open arm recorded in a 5 min observation period. *(p< .05), **(p< .01), 
(Dunnett’s test.), compared with control group 
 
 
Figure 2A: Effect of Mucuna pruriens (MP) and Buspirone (5 mg/kg) in open arm in Elevated Plus Maze Apparatus 
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Figure 2B: Effect of Mucuna pruriens (MP) and Buspirone (5 mg/kg) in closed arm in Elevated Plus Maze Apparatus 
The column represents the mean of no. of entries in open arm recorded in a 5 min observation period. *(p< .05), **(p< .01), 
(Dunnett’s test), compared with control group 
 
RESULT AND DISCUSSION  
In many previous studies, reported that extract of Mucuna 
pruriens did not produce any toxicity, or significant 
behavioral change, or mortality upto an oral dose of 2000 
mg/kg in albino mice 14. In the elevated plus maze, the open 
arms are more distress provoking, vulnerable and 
Anxiogenic than the closed arms. So, the animal likes to 
spend more time and shows normal rearing behavior in the 
closed arm. The ratio of entries, time spent and rearing 
behavior in open arms to closed arms reflects the safety of 
closed arms with relative fearfulness of open arms 15. The 
reduction in entry, time spent, rearing in open arms, ratio of 
open arm to total arm entries and increased defecation are 
the indications of high level of fear or anxiety. Anxiolytic 
drugs increase the proportion of entries, time spent and 
rearing in open arms. They also increase the ratio of open 
arm to total arm entries 16. Mucuna pruriens extract at the 
dose of 200 mg/kg and 400 mg/kg exhibit significant 
(p<0.05) increase in the time spent in the open arms and at 
the dose of 400 mg/kg it showed significant (p<0.05) 
increase in number of entries in open arm (Figure 2).  
Additionally, MPE 200 and 400 mg/kg had decrease in time 
spent and number of entries in closed arm (Table 1) as 
compared to control group showed a significant (p<0.05) in 
elevated plus-maze. Antianxiety effect of MPE at the dose of 
400 mg/kg is comparable to the antianxiety effect of 
diazepam 17. 
CONCLUSION 
The results of the present study indicate that Mucuna 
pruriens on administration, showed significant anxiolytic 
activity in the animal models studied. The presence of L-
DOPA and 5-hydroxy tryptophan (5-HTP) as a major 
constituent in Mucuna pruriens may suggest the role of 
dopaminergic and/or serotonergic pathways in its anxiolytic 
activities. However, advance studies are required to clarify 
the targets of action and the exact mechanism of action of 
Mucuna pruriens as an antianxiety drug. 
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